Varta
← Back to stories

From NDTV

Center-Right Owned by Adani Group (AMG Media)

Sun Pharma Brokerage Review: Citi, HSBC Maintain Buy; BofA Retains Underperform

Sun Pharma Brokerage Review: Citi, HSBC Maintain Buy; BofA Retains Underperform

RSS excerpt

Ilumya's US sales challenges, higher R&D spending, and the growth prospects of Leqselvi and Unloxcyt remain key factors shaping brokerage views on Sun Pharma.

✦ Single Source 1 news outlet reporting

Fact-Check & Bias Analysis

Reported by a single newsroom so far. Other outlets have not independently corroborated this story yet.

Coverage Bias Distribution

Based on 1 reporting publisher
Left / Center-Left 0 (0%)
Center 0 (0%)
Center-Right / Right 1 (100%)

Read more news

See all latest stories →